Save the date for HTID 2023
BIOTECH INFO - Save the date 5th HealthTech Innovation Days 24 & 25 OCTOBER 2023 in Paris 27 October 2023 virtual only:…
The Life Sciences Acceleration Alliance e.V. (LSAA) is a coalition of venture capitalists, corporate leaders, and subject matter experts dedicated to strengthening life sciences innovation and development in the EU seeking to ensure that policy in Europe evolves towards medical discovery, commercialisation and the benefit to patients.
There is an opportunity for proactive policies that could better commercialise innovation and yield economic and health benefits
BIOTECH INFO - Save the date 5th HealthTech Innovation Days 24 & 25 OCTOBER 2023 in Paris 27 October 2023 virtual only:…
LES ECHOS - The European Commission's ongoing review of legislation governing the pharmaceutical, life sciences and biotechnology industries raises many questions, including…
MARKET ACCESS & HEALTH POLICY - In order for ideas and findings of start-ups in the life sciences sector to be turned…
The importance of venture capital in Europe’s life science ecosystem: LSAA Report With the ongoing revision of the EU’s pharmaceutical legislation, there…
FINANZMARKTNACHRICHTEN - With venture capital to the forefront of the life sciences: Young, innovative start-up companies turn ideas and findings from life…
LSAA sponsors and attends BioEurope 2022 Bio-Europe Leipzig, from October 24 – 26, 2022, was an opportunity for leaders in biotech, pharma,…
BIOTECH FINANCES - On 17 June, the WTO decided to waive intellectual property rules on patents and data for COVID-19 vaccines. This…
LSAA raises concern about the European Commission’s support of TRIPS waiver: In response to the European Commission’s recent announcement that the European…
Here you can change your privacy preferences.